Updated:
RC Capital
RC Capital is a growth equity firm that builds high-potential healthcare companies by leveraging the interplay of device, services and HCIT. The firm invests...
RC Capital
RC Capital is a growth equity firm that builds high-potential healthcare companies by leveraging the interplay of device, services and HCIT. The firm invests in companies that enable clinicians to improve care delivery and patient experiences and outcomes. Its portfolio companies provide tools, services and tech that increase access to care, diagnose and treat problems earlier, lower costs of care delivery and relieve clinicians of administrative burdens.
General information
Firm type
Private Equity
Year founded
1994
Location
Region
North America
Country
United States
City
Cincinnati
Corporate office
Cincinnati, OH, United States
Principals
Daniel Fleming
Managing Partner
J. Carter McNabb
Managing Partner
Robert Heimann
Managing Partner
Rurik Vandevenne
Managing Partner
Sector focus
Frequently asked questions
How does RC Capital source proprietary deal flow in healthcare?
RC Capital sources deals through its network of portfolio company executives, operating advisors, and limited partners, reinforced by an annual Healthcare Operator Summit that gathered over 70 executives. The firm's three-segment focus — medical devices, healthcare services, and healthcare IT — lets it identify opportunities at the intersections where many sector-dedicated funds do not look.
Does RC Capital invest in early-stage or pre-revenue healthcare companies?
RC Capital targets lower middle market, growth-stage healthcare companies. Its active portfolio companies, including Standard Bariatrics and ModifyHealth, operate with commercial products and services. The firm does not publicly emphasize seed or pre-revenue investing.
What sectors does RC Capital explicitly avoid?
RC Capital focuses exclusively on three healthcare segments: medical devices, healthcare services, and healthcare IT. It does not invest in biotech, pharmaceuticals, or non-healthcare industries. The firm makes no mention of payer-side or health insurance investments in its public portfolio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: